President Trump: Morning-after stock winners, losers - UPDATES

3:30 PM: Freed from the prospect of President Clinton forcing down prices, U.S.-focused drugmakers are on a roll. Malvern-based Endo Pharmaceuticals is up 12%, Pfizer up 9%, Merck up 7%.  Among the multinationals, Glaxo and AstraZeneca are up around 4% each.

Sunoco Logistics was up 7 %, while Energy Transfer Partners, the Texas-based company that is building the Dakota Access pipeline Sunoco Logistics is scheduled to manage, rose 11%, on hopes the stalled project will be completed under President Trump.

Consumer-finance stocks were up, too. Navient, the Wilmington student-loan finance company, was up 19%, the best performance of any S&P 500 stock. United Rentals, which leases furniture to poor people at high prices; and Ameriprise Financial, the online broker, were also up double digits on expectations Trump will cancel pro-consumer regulation -- and maybe even reverse the Labor Department "fiduciary rule" that was supposed to force insurance agents and others to sell only products that benefited customers.

LockheedMartin and Unisys each rose over 6% on hopes of higher military spending.

Headed sharply lower were the healthcare-management stocks that had profited from Obama's expansion of Medicaid -- plan manager Centene Corp., King of Prussia-based Universal Healthcare, Hospital Corp. of America were all off sharply.

So were some trade-related stocks, including the U.S.-Mexico rail shipper KC Southern.

10:15 AM: After last night's steep, short dive the S&P 500 and Dow-Jones 30 Industrial big-company stock averages are up this morning, as traders weigh Trump's promise to cut corporate income taxes and boost infrastructure and military spending against his threats to end health-insurance subsidies and trade deals.

At 10:15 a.m. the two top-performing S&P 500 companies were both Philadelphia-area companies:

- Endo Pharmaceuticals of Malvern was up 14%; Pfizer and other drug stocks also soared, on the promise drug development regs and government-health  price controls will ease;
- Navient, the Wilmington-based student lender, was also up 14%, on hopes a Trump administration will scrap consumer finance regulations and privatize student lending (as past GOP administrations have done).

Also:
- Nucor, one of the largest surviving U.S. steelmakers, was up 12% on hopes the U.S. will respond more forcefully to price-dumping allegations against China steelmakers;
- United Rentals rose 12%, on hopes of easier regulation for high-interest lending and leasing;
- Jacobs Engineering was up 9% on hopes of increased highway and infrastructure spending.

Big losers included, for example:
- Hospital Corp. of America, which profited from "Obamacare" subsidies, down 14%